| Stragen Pharma SA - Urapidil Stragen i.v. 25 mg, solution injectable |
| 66012 | | 01 | | Urapidil Stragen i.v. 25 mg | | solution injectable | | C02CA06 | | Urapidil | | 21.04.2016 | | |
|
| Composition |
| urapidilum 25 mg, acidum hydrochloridum concentratum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, propylenglycolum 500 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 2.18 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Urapidil | 25mg / 5ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum | | | Acidum Hydrochloridum Concentratum | | | Disodium Phosphate Dihydrate | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydroxide | | | Propylenglycol | 500mg / 5ml |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 x 5 ml | | | B | | Non |
|
